Together these effects have been shown to reduce glycemia and improve metabolic associated steatotic liver disease [18, 44]
Joseph M
See How to Read a Janoshik COA and the Lab Results page
However, following a balanced and nutritious diet is essential for optimizing weight loss results
"The progression of elecoglipron is an important step in delivering a differentiated weight management portfolio, offering monotherapies and combinations, designed to address the biological complexity of obesity and comorbidities that can be tailored to individual needs, enabling people to live healthier lives." Sharon Barr, Executive Vice President, BioPharmaceuticals R&D, AstraZeneca Weight Loss Results In AstraZeneca's VISTA Phase 2b trial , adults living with obesity or overweight plus at least one weight-related condition lost an average of 10.5% of their body weight after 26 weeks on the highest dose of elecoglipron
This is the phase that creates longer-lasting results, even after blood levels drop